Value of plasma neurofilament light chain for monitoring efficacy in children with later-onset spinal muscular atrophy under nusinersen treatment
Jianing Jin,Yijie Feng,Siyi Huang,Yiqin Cui,Liya Jiang,Yue Yan,Yicheng Yu,Dongming Zhou,Feng Gao,Shanshan Mao
DOI: https://doi.org/10.1515/cclm-2023-1119
2024-02-20
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:Funding source: National Natural Science Foundation of China Award Identifier / Grant number: 82271735 Funding source: Fundamental Research Funds for the Central Universities Funding source: the Key R&D Program of Zhejiang Award Identifier / Grant number: 2022C03167 The authors want to thank Isaac Liu and Andrew Dy for their contribution to the study design. The authors are grateful to all the patients who participated in this study. Research ethics: This study was approved by the Ethics Committee of Children's Hospital, Zhejiang University School of Medicine (2020-IRB-186). Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: The authors state no conflict of interest. Research funding: This study was supported by the National Natural Science Foundation of China (82271735), the Key R&D Program of Zhejiang (2022C03167), and the Fundamental Research Funds for the Central Universities. Data availability: The raw data can be obtained on request from the corresponding author. 1. Khalil, M, Teunissen, CE, Otto, M, Piehl, F, Sormani, MP, Gattringer, T, et al.. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 2018;14:577–89. https://doi.org/10.1038/s41582-018-0058-z. Search in Google Scholar PubMed 2. Lunn, MR, Wang, CH. Spinal muscular atrophy. Lancet 2008;371:2120–33. https://doi.org/10.1016/s0140-6736(08)60921-6. Search in Google Scholar 3. Mercuri, E, Darras, BT, Chiriboga, CA, Day, JW, Campbell, C, Connolly, AM, et al.. Nusinersen versus Sham control in later-onset spinal muscular atrophy. N Engl J Med 2018;378:625–35. https://doi.org/10.1056/nejmoa1710504. Search in Google Scholar PubMed 4. Jin, J, Wei, J, Feng, Y, Cui, Y, Zhou, D, Yao, M, et al.. Plasma neurofilament light chain in Chinese children with later-onset spinal muscular atrophy. Clin Chem Lab Med 2022;60:e237–9. https://doi.org/10.1515/cclm-2022-0637. Search in Google Scholar PubMed 5. Nitz, E, Smitka, M, Schallner, J, Akgün, K, Ziemssen, T, von der Hagen, M, et al.. Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children. Ann Clin Transl Neurol 2021;8:2013–24. https://doi.org/10.1002/acn3.51449. Search in Google Scholar PubMed PubMed Central 6. Wurster, CD, Steinacker, P, Günther, R, Koch, JC, Lingor, P, Uzelac, Z, et al.. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen. J Neurol 2020;267:36–44. https://doi.org/10.1007/s00415-019-09547-y. Search in Google Scholar PubMed 7. Jin, J, Cui, Y, Hong, Y, Zhou, D, He, N, Mao, Z, et al.. Reference values for plasma neurofilament light chain in healthy Chinese children. Clin Chem Lab Med 2021;60:e10–12. https://doi.org/10.1515/cclm-2021-0804. Search in Google Scholar PubMed 8. Wurster, CD, Günther, R, Steinacker, P, Dreyhaupt, J, Wollinsky, K, Uzelac, Z, et al.. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment. Ther Adv Neurol Disord 2019;12:1756286419846058. https://doi.org/10.1177/1756286419846058. Search in Google Scholar PubMed PubMed Central © 2024 Walter de Gruyter GmbH, Berlin/Boston
medical laboratory technology